Leading cardiologists from Bombay Hospital and Jaslok Hospital have recently placed Bioresorbable Vascular Scaffold (BVS), the fourth generation coronary stents for the first time in India. The BVS “Absorb”, developed by Abbott Vascular, is the fourth revolution in Intervention Cardiology.
BVS is unique and it disintegrates and disappears in the body within two years.
After its official launch by Abbott in the country recently, Dr B K Goyal, director - cardiology, Bombay Hospital along with his team of doctors, today performed this breakthrough procedure in a 37 year-old-man and team of doctors at Jaslok Hospital namely, Dr A B Mehta, Dr Ajit Desai and Dr S R Handa placed the bioresorbable stent, “Absorb” in a 57 years old man.
“For the first time, young patients will benefit from this revolutionary therapy as it provides options for future interventions unobstructed by a permanent implant. It will eliminate sources of vessel inflammation and irritation and restore it to a more natural state. Also, patients may no longer require the prolonged anti-platelet (DAPT) therapy for lifelong,” said Dr B K Goyal, director – Cardiology, Bombay Hospital.
“The learning curve for the doctors is simple and easy for this kind of stents. One must possess full knowledge about the stent and the blocked area in the artery should be adequately opened before such a stent. In a time to come, this will replace currently used metallic stents completely,” explains Dr A B Mehta, interventional cardiologist, Jaslok Hospital.